Digital stethoscope: Technology update by Swarup, S. & Makaryus, A. N.
Journal Articles Donald and Barbara Zucker School of MedicineAcademic Works
2018
Digital stethoscope: Technology update
S. Swarup
A. N. Makaryus
Zucker School of Medicine at Hofstra/Northwell
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Cardiology Commons
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.
Recommended Citation
Swarup S, Makaryus AN. Digital stethoscope: Technology update. . 2018 Jan 01; 11():Article 3262 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/3262. Free full text article.
© 2018 Swarup and Makaryus. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Medical Devices: Evidence and Research 2018:11 29–36
Medical Devices: Evidence and Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
29
R E v i E w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/MDER.S135882
Digital stethoscope: technology update
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Abstract: Cardiovascular disease (CVD) is recognized as the leading cause of mortality through-
out the world. About one-third of global mortality is attributable to CVD. In addition to clinical 
presentation, specific clinical exam findings can assist in treating and preventing CVD. CVD 
may initially manifest as pulmonary pathology, and thus, accurate cardiopulmonary ausculta-
tion is paramount to establishing accurate diagnosis. One of the most powerful tools available 
to physicians is the stethoscope. The stethoscope first emerged in the year 1818, invented by 
a French physician, René Laennec. Since then, the initial modest monaural wooden tube has 
evolved into a sophisticated digital device. This paper provides an analysis of the evolution of 
the stethoscope as well as highlights the advancement made by the modern digital stethoscope 
including the application of this tool in advancing care for patients suffering from CVD.
Keywords: cardiovascular disease, physical exam, diagnosis, treatment
Introduction
Cardiovascular disease (CVD) is recognized as the leading cause of mortality in coun-
tries throughout the world, and thus, timely detection, treatment, and prevention are the 
cornerstone of the comprehensive care that a physician provides to his/her patients.1 
In 2015, 31% of global mortality was attributable to CVD, where 17.7  million people 
died from a cardiac cause.1 Auscultation of the cardiovascular system can assist in 
timely diagnosis of valvular heart disease (VHD), congestive heart failure, hypertensive 
disease, arrhythmias such as atrial fibrillation, obstructive arterial disease, and struc-
tural heart disease among several others. Furthermore, multiple pulmonary diseases 
can manifest as right-sided heart disease and multiple heart diseases can first present 
as pulmonary pathology; thus, pulmonary auscultation and interpretation can further 
assist in forming accurate diagnosis.
Cardiovascular examination usually comprises the following: evaluation of the 
carotid arterial pulse and jugular venous pulse; auscultation for bruits; auscultation 
of venous hums, precordial impulses, and palpation of heart sounds and murmurs; 
auscultation of the heart sounds; and evaluation of the peripheral arterial and venous 
system.2 Auscultation of the heart sounds is the foundation upon which a physician 
can diagnose CVD and provide cost-effective means for additional tests. Auscultation 
represents recognition of mechanical vibration from the body surface at the frequency 
range of sound (20–20,000 Hz).3 Vibrations below this frequency range are defined 
as “infrasonic” and are usually appreciated as thrusts, heaves, and arterial or venous 
pulsations.
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In the modern world, several modalities are used in addi-
tion to the clinical examination in evaluation of CVD. An 
electrocardiogram (ECG) is an inexpensive and noninvasive 
test that can assist in recognition of arrhythmias and acute 
coronary syndromes and can be used as a screening tool for 
CVD.4 Other modalities include the echocardiogram, cardiac 
magnetic resonance imaging (CMRI), and computed tomog-
raphy (CT). Echocardiography uses reflected ultrasound 
waves to give information regarding cardiac hemodynamics, 
function, and structure. It is a powerful tool that is generally 
used in addition to ECG and chest X-ray for initial CVD 
assessment.5 CMRI uses magnetic resonance imaging to 
provide clear delineation of the cardiac anatomy, provides 
a detailed myocardial tissue analysis that aids in diagnosis 
of specific cardiomyopathies, provides myocardial viability 
data, and can assist in evaluation of cardiac function.6 CT uses 
X-rays in the acquisition of data with high spatial resolution. 
Cardiac CT today can be used to assess atherosclerosis in 
coronary artery disease, compute a calcium score, evalu-
ate the cardiopulmonary vasculature, and evaluate valves.7 
However, despite advances in these imaging modalities, each 
technique requires a technician trained to perform these tests 
and an experienced operator who can interpret the findings 
accurately. In addition, these machines are usually only 
available in large institutions, leaving many underserved 
areas without such advanced technology to aid in diagnosis 
and treatment of CVD.1 Thus, it is imperative for a physician 
to develop clinical acuity as well as employ easily available 
tools such as a stethoscope for a timely diagnosis and treat-
ment of CVD.
The conventional stethoscope
The stethoscope is an acoustic device that transmits the 
sounds from the chest piece through an air-filled hollow 
tube to the listener’s ears. The French physician René 
Laennec first invented it in the 1800s. The design was 
modest and consisted of a hollow wooden tube that was 
monaural. Around the same time period, a British physi-
cian, Golding Bird, described his version of the stethoscope 
that comprised flexible tubing that was also monaural. 
Later, an Irish physician, Arthur Leared, advanced the 
design and a binaural stethoscope emerged.8 The binaural 
stethoscope has evolved tremendously since then; however, 
the concept remains the same. The current acoustic binaural 
stethoscope consists of a hollow tube attached to a chest 
piece consisting of a wider-based diaphragm and a smaller 
hollow bell. The diaphragm will transmit higher frequency 
sounds, whereas the bell will transmit lower-frequency 
sounds. Thus, the acoustic stethoscope will attenuate sound 
transmission proportional to the frequency created by the 
heart sounds. Due to the variation in sensitivity of a human 
ear, some sounds may not be heard due to low frequency, 
such as below 50 Hz. This limitation of the acoustic stetho-
scope has led to the emergence of an electronic device that 
is far more sophisticated than the original conventional 
stethoscope (Figure 1).
Figure 1 Main components of the conventional stethoscope.
Eartips
Binaural
Binaural spring Stem
Flexible tubing
Chest piece with tunable diaphragm allowing
simulation of a diaphragm for high
frequencies or a bell for low frequencies
based on pressure change
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Cardiac and pulmonary auscultation
It is vital for a physician to appreciate cardiac and pulmonary 
sounds in his/her patients in order to accurately formulate 
a diagnosis. Auscultation with a stethoscope provides clini-
cal information that can assist in diagnosing, and altering 
and directing patient care. Heart sounds are created due to 
opening and closure of the valves, blood flow through any 
orifice, flow of blood into the ventricular chambers, and rub-
bing of the cardiac surfaces.9 Heart sound frequencies can be 
impacted by valve apparatus; however, they normally range 
from 10 to 200 Hz.10,11 The main areas of auscultation are 
depicted in Figure 2.
Normal heart sounds comprise the first heart sound (S1), 
which is produced by the closure of the atrioventricular (AV) 
valves that are the mitral and tricuspid valves. This corre-
sponds to the end of diastole and the beginning of ventricular 
systole and precedes the upstroke in the carotid arteries.9–12 
Variability in auscultation of S1 is described in Figure 3.
The second heart sound (S2) is due to the closure of the 
aortic valve (A2) and the pulmonic valve (P2) at the  conclusion 
Figure 2 Main areas of cardiac auscultation.
Abbreviation: iCS, intercostal space.
Base of the heart
Interscapular area
Pulmonary area: 2nd
ICS left of sternum
Left axilla
Tricuspid area: 4th and
5th ICS left of sternum
Mitral area: Cardiac
apexApex of the heart
Carotid arteries
Aortic area: 2nd ICS
right of the sternum or
3rd ICS left of
the sternum
Figure 3 variability of auscultation of S1. Adapted from Leng S, Tan RS, Chai KT, wang C, Ghista D, Zhong L. The electronic stethoscope. Biomed Eng Online. 2015;14:66. 
Creative Commons license and disclaimer available from: http://creativecommons.org/publicdomain/zero/1.0/.15
Note: S1 is the first heart sound.
Abbreviations: MS, mitral stenosis; TS, tricuspid stenosis; MvP, mitral valve prolapse; Lv, left ventricular; ASD, atrial septal defect; Av, atrioventricular; MR, mitral 
regurgitation; TR, tricuspid regurgitation; DCM, dilated cardiomyopathy; CM, cardiomyopathy; Mi, myocardial infarction; M1, mitral valve; T1, tricuspid valve; Rv, right 
ventricular.
Loud S1: Increased transvalvular gradient
(MS, TS, atrial myxoma), increased force of
ventricular contraction (tachycardia,
hyperdynamic states), shortened PR interval
(tachycardia, preexcitation syndromes ex
Wolff–Parkinson–White syndrome), MVP
Diminished S1: Inappropriate apposition of the
AV valves (MR, TR, DCM), prolonged PR
(bradycardia, heart block, digoxin toxicity),
decreased force of ventricular contraction
(CM, MI), increased calcification of AV valve,
increased distance from
the heart (pericardial effusion, obesity,
emphysema, pleural effusion)
Reverse splitting S1 (M1 follows the
closure of T1): Left bundle branch block,
RV pacing, severe MS,
left atrial myxoma
Muffled S1: Pleural
effusion, pericardial
effusion, pneumothorax,
emphysema, obesity
Split S1: Premature ventricular contraction,
right bundle branch block, LV pacing, ebstein
anomaly, ASD
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of systole, and it marks the beginning of the diastolic period. 
Variability in auscultation of S2 is further described in Figure 4.
The third heart sound (S3) occurs in early diastole as the 
blood enters the ventricle from the atria. It can be normal in 
individuals up to the age of 40 years; however, if audible in 
patients of older age, then S3 is pathologic. Pathologically, 
this can be due to systolic or diastolic ventricular dysfunction, 
ischemic heart disease, hyperkinetic states (fever, anemia, preg-
nancy, thyrotoxicosis, AV fistula), VHD, or volume overload.9
The fourth heart sound (S4) is a late diastolic sound and 
is usually produced when the blood from the atria is sud-
denly decelerated due to a noncompliant left ventricle. Thus, 
ventricular hypertrophy, ischemic heart disease, ventricular 
aneurysm, and hyperkinetic states causing forceful atrial 
contraction can all produce an S4.9–12
In addition to the above heart sounds, an opening snap, 
valvular ejection clicks, and a variety of murmurs can also be 
appreciated.9 A summary of common murmurs is described 
in Table 1.
Furthermore, another vital component of auscultation is 
classification of pulmonary pathology to assist in making cor-
rect diagnosis. However, accurate interpretation of pulmonary 
auscultation is subjective and largely dependent on the training 
of the physician. Auscultation should take place in a quiet room 
Figure 4 variability of auscultation of S2. Adapted from Leng S, Tan RS, Chai KT, wang C, Ghista D, Zhong L. The electronic stethoscope. Biomed Eng Online. 2015;14:66. 
Creative Commons license and disclaimer available from: http://creativecommons.org/publicdomain/zero/1.0/.15
Notes: A2 represents the closure of the aortic valve. P2 is the closure of the pulmonic valve. S2 is the second heart sound.
Abbreviations: TGA, transposition of great arteries; AI, aortic insufficiency; AS, aortic stenosis; PAH, pulmonary arterial hypertension; ASD, atrial septal defect; PV, 
pulmonic valve; RBBB, right bundle branch block; Lv, left ventricular; PvC, premature ventricular contraction; wPw, wolff–Parkinson–white syndrome; Rv, right ventricle; 
PvS, pulmonic valve stenosis; Av, atrioventricular; MR, mitral regurgitation; vSD, ventricular septal defect; LBBB, left bundle branch block; PvR, pulmonary vascular 
resistance; SvR, systemic vascular resistance.
Intensity of A2: 1) Increased-systemic
hypertension, coarctation of the aorta,
aortic aneurysm, tetralogy of fallot and TGA.
2) Decreased – AI, calcific AS, decreased systemic
arterial pressure.
Intensity of P2: increases with PAH and ASD
Wide S2 splitting: 1) Delayed closure of PV –
conduction (RBBB, LV pacing, PVCs, WPW with
preexcitation of the LV) or hemodynamic
abnormalities (RV outflow tract obstruction, PAH,
PVS, pulmonary artery branch stenosis)
2) Early closure of AV: MR, VSD, left to right
shunting
Wide fixed S2 splitting (respiratory variability
between A2–P2 is lost): ASD with left to right
shunting, RV failure due to primary RV failure, PAH,
and RV outflow tract obstruction
Reverse S2 splitting: 1) Conductive disturbance
(LBBB, RV pacing, PVCs of RV origin,
preexcitation of RV in WPW)
2) Hemodynamic-LV outflow tract
obstruction caused by AS
Split S2: PVR is less than SVR
thus normally AV closes
slightly before PV and is
exaggerated with inspiration
Table 1 Description of common murmurs
Murmur Location Quality Description Radiation Pitch
AS Apex/RUS border Harsh Systolic, crescendo–decrescendo Carotid arteries High
AR RUS border/left 3rd–4th iCS Blowing Diastolic, decrescendo Apex
MS Apex Rumbling Mid-late diastolic with presystolic 
accentuation
Low
MR Apex Blowing Holo-systolic Axilla/base of heart High
PS Left 2nd iCS Blowing Systolic, crescendo–decrescendo High
TR Left 4th iCS Blowing Diastolic Left sternal border/xiphoid High
HOCM Left lower sternal border Harsh Mid-late systolic High
vSD Left lower sternal border Harsh Holo-systolic High
PDA Left upper sternal border Harsh Continuous crescendo–decrescendo with 
peak about S2
High
MvP Apex Blowing Mid-late systolic Axilla/base High
Note: Adapted from Leng S, Tan RS, Chai KT, wang C, Ghista D, Zhong L. The electronic stethoscope. Biomed Eng Online. 2015;14:66. Creative Commons license and 
disclaimer available from: http://creativecommons.org/publicdomain/zero/1.0/.15
Abbreviations: AS, aortic stenosis; RUS, right upper sternal;AR, aortic regurgitation; iCS, intercostal space; MS, mitral stenosis; MR, mitral regurgitation; PS, pulmonic stenosis; 
TR, tricuspid regurgitation; HOCM, hypertrophic obstructive cardiomyopathy; vSD, ventricular septal defect; PDA, patent ductus arteriosus; MvP, mitral valve prolapse.
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with the patient in a seated position. Auscultation should be 
done in a symmetrical fashion starting at the apices anteriorly 
moving to the base and then progression to the posterior chest. 
Patients should be asked to take deep breaths with their mouth 
open, while breath sounds should be evaluated for their quality, 
intensity, and for the presence of unanticipated sounds.
Normal frequency of pulmonary sounds varies from 100 
to 1000 Hz.13 Moreover, frequency of wheezing ranges from 
100 to 5000 Hz, rhonchus is 150 Hz, coarse crackle is 350 
Hz, and fine crackle is 650 Hz.13 Tracheal sounds that are 
normal are clearly heard in both phases of respiratory cycle, 
whereas normal lung sound is only heard on inspiration 
and early phase of expiration.14 Wheezing can be heard on 
inspiration, expiration, or both, and is musical in nature with 
a high pitch.14 Rhoncus may be heard on inspiration, expira-
tion, or both, and is low pitch in nature similar to snoring.14 
Fine crackles are heard on mid-to-late inspiration and can 
be heard on expiration, and are usually not transferred to the 
mouth and unaffected by cough.14 Coarse crackle is heard 
on early inspiration and throughout expiration, is affected by 
cough, and is transferred to the mouth.14 Pleural friction rub 
and stridor are explosive and high-pitch sounds, respectively, 
which can also be appreciated during auscultation.14 Since 
multiple pulmonary sounds can be appreciated, and at times 
simultaneously, digital stethoscope has facilitated in allow-
ing a clinician to accurately understand the pathology behind 
the sound. As seen by the information that can be gleaned as 
noted above, the stethoscope serves as an important tool to 
diagnose a plethora of cardiovascular and pulmonary disease 
processes by auscultating heart and lung sounds.
The emergence of the digital 
stethoscope
A digital stethoscope is able to convert an acoustic sound to 
electronic signals, which can be further amplified for optimal 
listening. These electronic signals can be further processed 
and digitalized to transmit to a personal computer or a lap-
top.15 The diagnostic power provided by digital stethoscope 
auscultation to a physician can assist in altering management 
in patient care (Figure 5).
The digital stethoscope consists of three different mod-
ules, data acquisition, preprocessing, and signal processing, 
before the listener can appreciate the auscultated sound.15 
The data acquisition module involves a microphone and a 
piezoelectric sensor. It is responsible for filtering, buffer-
ing, and amplification of the auscultated sounds, as well 
as conversion of the acoustic sound to a digital signal. The 
preprocessing module filters the digital signal and removes 
any artifacts. These digital data are then forwarded to the 
signal-processing module, which will package the informa-
tion in a higher-order classification and cluster the data for 
a clinical diagnostic decision.15
Unlike the acoustic stethoscope, the transducers on a 
digital stethoscope are of wide variety. One of the transducing 
Figure 5 Main components of the digital electronic stethoscope.
Eartips
Binaural
Binaural
spring
Flexible
tubing
Chest piece with diaphragm and electronic display.
Recoding and Bluetooth® capabilities are present.
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methods involves the microphone in the chest piece.16 The 
sound signals are detected by the stethoscope diaphragm, 
which is transferred to another diaphragm inside the micro-
phone. This allows for the conversion of a simple and direct 
acoustic sound to an electrical signal. The signal can then 
be displayed as a phonocardiogram on an electronic device 
(Figure 6). However, two diaphragms separated by an air path 
can result in excessive ambient noise signals and inaccurate 
electrical signal transfer.15
A piezoelectric sensor functions differently to the 
double-diaphragm mechanism. In a piezoelectric transducer, 
the sounds picked up by the stethoscope diaphragm cause 
distortion of a crystal substance that is responsible for then 
producing an electrical signal.16,17 The distortion of the crystal 
can produce the electrical signal that may not truly capture 
the original sound ascertained by the diaphragm.15
A capacitive micro-electromechanical system is another 
modality used for a transducer. The diaphragm of the stetho-
scope is suspended in a nominal capacitance field, where 
the capacitance changes according to the acoustic pressure 
formed by the heart sound. The change in capacitance is able 
to generate an electrical signal.18
Currently, almost all available digital stethoscopes allow 
for selection of different frequency response modes allowing 
the listener to better hear sounds from the heart, lung, and 
other areas of the body. There are also multiple mechanisms by 
which a digital stethoscope can suppress ambient and friction 
noise to allow the listener to hear sounds that are as original as 
possible. For instance, the 3M® Littmann Range offers piezo-
electric sensor which uses the ambient noise reduction as an 
adaptive noise canceller by which it allows to amplify sounds 
up to 24 times.19 The Thinklabs® One Digital stethoscope is 
able to amplify sounds up to 100 times by applying capacitive 
transducer.20 This technology is able to employ ambient noise 
reduction but can also use specific heart sound extraction 
creating a rigorous tool to hear specific heart sounds such as 
valvular clicks as well as use specific computer algorithms to 
extrapolate frequencies to understand pulmonary pathology.20 
The Welch-Allyn® Elite Electronic Stethoscope allows for a 
bell mode ranging from 20 to 420 Hz, specifically for heart 
sounds, and diaphragm mode ranging from 350 to 1900 Hz, 
which is better used for lung auscultation.21 Furthermore, the 
Ekoscope® stethoscope offers built-in ECG capability, and the 
ViScope® stethoscope can empower a physician with real-time 
display of multiple waveforms.22,23 A digital stethoscope also 
allows the operator to record the heart sounds and upload 
them to a computer for further visualization, analysis, and 
transmission. Additionally, some digital stethoscopes can 
also be connected to Bluetooth® to wirelessly transmit sound 
signals to a remote processing unit.
Medical advancements and 
applications in cardiac and 
pulmonary auscultation
Aside from providing increased precision and audible advan-
tage over the conventional stethoscope, digital stethoscopes 
have also been studied for their utility of screening for 
obstructive coronary artery disease. Turbulent blood flow 
occurs due to hemodynamically significant coronary artery 
disease and manifests as intracoronary murmurs. However, 
conventional stethoscopes lack the auscultation power to 
detect these murmurs. We studied the correlation between 
diagnosis of coronary artery disease using an electronic 
stethoscope and lesions noted on cardiac CT.24 In our pro-
spective single-site study, we wanted to study the accuracy 
in correlation between the severity and location of coronary 
artery disease seen on cardiac CT and the microbruits pro-
cessed by the Cardiac Sonospectrographic Analyzer (CSA; 
SonoMedica, Vienna, VA, USA) of the electronic stetho-
scope. A total of 161 patients were studied, and the overall 
sensitivity of the CSA to ascertain coronary artery disease of 
>50% in any major epicardial artery was 89.5% (p < 0.001).24
Similarly, Azimpour et al studied similar correlation 
between audible intracoronary murmurs using a digital 
stethoscope and the findings on coronary angiography.25 In 
123 patients, they were able to ascertain the sensitivity and 
specificity of acoustic detection of lesions with >50% stenosis 
in any coronary artery to be 0.70 and 0.80, respectively.25
The promise of this new tool to supplement noninvasive 
imaging in the diagnosis of obstructive coronary disease rests 
on the premise that small audible signals generated by the 
turbulent flow in the coronary artery can be appreciated. The 
CSA, CADence™, and CADScor®System are a few examples 
of acoustic detection systems that are currently being studied 
to validate against CT and invasive coronary angiography.26 
A summary of recent studies is provided in Table 2.
Figure 6 Simulated phonocardiogram of normal S1 and S2 heart sounds seen on a 
portable device through Bluetooth® integration.
Note: S1 and S2 represent the first and the second heart sound respectively.
S1 S2
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Furthermore, due to the innovation of the digital stetho-
scope and the capability to transmit the heart sounds wire-
lessly, there is potential to develop and advance the field of 
telemedicine.27 This will allow physicians to access patients’ 
heart sounds live and alter care and trajectory of their health 
directly.
Digital aspect of pulmonary auscultation involves record-
ing of the pulmonary sound, computer analysis of the signals 
obtained, and classification of the sounds based on the fre-
quency analyses.28 Computer-based pulmonary sound analysis 
allows for optimizing and quantifying auscultated lung sounds 
based on the lung sound as well as the spectral characteristics. 
The Fourier transform has been the most common analysis 
tool that has been used to understand pulmonary ausculta-
tion.28 The Fourier transform is able to degenerate the signal 
to the frequencies that comprise the signal. Neural network, 
which is a machine-learning algorithm, can further process 
this information and classify the different frequencies into 
pulmonary sounds.28 Gurung et al performed a meta-analysis 
of studies that have tried to understand the prognostic power 
of combining digital pulmonary auscultation with computer-
based algorithms. Although the sample size was limited, 
they were able to uncover that the specificity and sensitivity 
of identifying abnormal pulmonary sounds using computer-
based algorithms were 85% and 80%, respectively.28
It is also important to note that multiple cardiopulmonary 
pathologies are connected, and researchers have started to 
use digital technology to garner accurate diagnosis. For 
instance, Kaddoura et al used automated machine learn-
ing and language-recognition-inspired-speech algorithm to 
ascertain if the digitally acquired heart sounds were linked to 
pulmonary hypertension (PH).29 The algorithm used was able 
to closely examine the heart sound and collect information 
such as amplitude, intensity, shape, and frequency. The heart 
sounds from PH patients were compared to non-PH patients, 
and they discovered the algorithm accurately diagnosed PH 
74% of the time.29 These recent discoveries have opened 
the door for further research to further optimize the current 
technology, to ultimately empower the physician to better 
assist the patient.
Conclusion
Multiple cardiopulmonary pathologies can be appreciated 
by the simple mechanism of auscultation. The prevalence 
of CVD is rising in the world, and multiple CVDs may first 
manifest as pulmonary symptoms; thus, it is imperative that 
a physician has the ability to accurately examine a patient 
even with limited resources. The stethoscope is a powerful 
tool that is easy to use and allows for direct impact on patient 
care. With multiple sophisticated advancements made in 
medicine, which aid in clinical diagnosis and management, 
none of the modalities compare to the simplicity and vitality 
of a stethoscope. The emergence of a digital stethoscope has 
only made this historic tool even more refined. The physician 
can now hear heart and lung sounds with more accuracy and 
precision. Through this advancement, there is now potential 
Table 2 Summary of recent studies utilizing acoustic detection system in diagnosing obstructive coronary artery disease
Acoustic detection system Technology Title and results References
CSA SonoMedica model 3.0 CSA is a noninvasive digital 
electronic stethoscope devised to 
identify microbruits in the frequency 
range of 400–2700 Hz
Utility of an advanced digital electronic stethoscope 
in the diagnosis of coronary artery disease compared 
with coronary computed tomographic angiography
24
Results: SonoMedica stethoscope with CSA predicted 
presence of CAD with sensitivity of 89.5% and 
specificity of 57.7%
CADence™ ironman CADence is a noninvasive device 
which combines bedside auscultation 
with echocardiographic data which 
is transmitted to a central server for 
analysis, and final report is sent to 
the physician
Unpublished study of 1000+ patients from UCLA 30
Designed by Aum Cardiovascular Results: in a moderate-risk population, obstructive 
CAD can be detected with sensitivity of 81% and 
specificity of 83%
CADScor® System (Acarix A/S) 
microphone
CAD-score algorithm system 
includes acoustic properties of heart 
sounds combined with clinical risk 
factors
Diagnostic performance of an acoustic-based system 
for coronary artery disease risk stratification
31
System is mounted at the fourth 
intercostal space applying a 
dedicated adhesive patch, and 
heart sounds are analyzed using 
automated and device-embedded 
algorithm
Results: Low risk is indicated by a CAD-score value 
≤20. At this cutoff, hemodynamically significant CAD 
was detected with sensitivity of 81% and specificity of 
53% with NPv of 96%
Abbreviations: CSA, Cardiac Sonospectrographic Analyzer; CAD, coronary artery disease; UCLA, University of California, Los Angeles; NPv, negative predictive value.
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to auscultate for obstructive coronary artery disease, and other 
bruits and obstructive vascular diseases such as carotid artery 
stenosis, and examine multiple frequencies that may comprise 
pulmonary auscultation. Furthermore, there is also potential 
to drastically impact patient care by appreciating disease pro-
cesses earlier and to prevent fatal outcome. Medical care can 
also be provided in areas that are underserved or which do not 
have medical facilities by applying digital stethoscope tech-
nology to telemedicine to allow remote assessment. Although 
research still needs to be implemented to validate the digital 
stethoscope further, currently this tool allows the user to be a 
better diagnostician and thereby deliver better medical care.
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